10-Q · May 8, 2026
Inogen reported Q1 2026 results with revenue of $85.1 million, surpassing expectations by 3.4%, but net loss widened to $8.3 million. The company faced a significant decline in U.S. rental revenue, although…
Earnings analysis · 10-Q
INGN earnings analysis
Filed August 7, 2026 · Our reading of the company's report
The latest report
Q2 2026 revenue was $95.084 million, increasing approximately 11.9% sequentially and 3.4% year over year, while EPS improved to $0.00 from losses of $0.30 in Q1 2026 and $0.15 in Q2 2025. The supplied filing text does…
Read full summary
Q2 2026 revenue was $95.084 million, increasing approximately 11.9% sequentially and 3.4% year over year, while EPS improved to $0.00 from losses of $0.30 in Q1 2026 and $0.15 in Q2 2025. The supplied filing text does not provide gross margin, operating margin, cash flow, balance-sheet, segment, or quantitative outlook data, limiting the assessment of underlying operating performance. Share repurchases continued, with 847,050 shares bought at an average price of $6.64 and $22.5 million remaining under the authorization. Risk factors were unchanged from prior filings.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $0.0
What stood out
-
Revenue grew sequentially and year over year
Q2 revenue was $95.084 million, up from $85 million in Q1 2026, an increase of approximately 11.9%, and up from $92 million in Q2 2025, an increase of approximately 3.4%.
-
EPS improved to break-even
Reported EPS was $0.00 versus negative $0.30 in Q1 2026 and negative $0.15 in Q2 2025, indicating a sequential and year-over-year improvement in per-share earnings.
-
Share repurchases continued
The company repurchased 847,050 shares during Q2 at an average price of $6.64 per share, under the $30.0 million February 2026 authorization.
-
Repurchase authorization remains available
At June 30, 2026, $22.5 million remained available under the share-repurchase program, which expires December 31, 2027, unless fully utilized earlier.
-
Controls remained effective
Management concluded that disclosure controls and procedures were effective at the reasonable-assurance level as of June 30, 2026, and reported no material change in internal control over financial reporting during the quarter.
What to watch
-
Ongoing share-repurchase liquidity use
The company repurchased 847,050 shares for approximately $5.6 million during Q2, based on 847,050 shares at an average price of $6.64. The program had $22.5 million remaining under its $30.0 million authorization, representing a potential future use of liquidity.
-
Litigation costs and management diversion
The filing states that litigation and investigations arising in the normal course could create defense and settlement costs and divert management resources, although the company does not anticipate a material adverse effect from these proceedings.
-
No material risk-factor changes disclosed
No material changes to previously disclosed risk factors were identified relative to the 2025 Form 10-K filed February 27, 2026, or the Q1 2026 Form 10-Q filed May 8, 2026. Accordingly, the filing provides no new quantified risk-factor update.
Management's outlook
The supplied 10-Q text does not include quantitative revenue or EPS guidance. The prior 8-K cited full-year revenue guidance of $366 million to $373 million, but this filing does not explicitly reaffirm or change it.
Earlier filings 4
10-Q · August 8, 2025
Inogen reported Q2 revenue of $92,277,000 (up $3,512,000 vs Q2 2024 and up ~$10.0M vs Q1 2025) with gross margin of 44.8% and an improved operating margin of -6.6%. GAAP diluted net loss per share narrowed to $(0.15)…
10-Q · November 8, 2024
Inogen reported Q3 revenue of $88,834,000 (up from $83,967,000 a year ago) and a narrower GAAP loss per share of $0.25 (basic and diluted) for the quarter. Gross margin expanded to 46.5% from roughly 40.2% a year ago…
10-K · March 1, 2024
Inogen 10-K emphasizes a growth strategy built on direct-to-consumer sales and rental penetration in the U.S., continued product innovation (Rove 6, Inogen Connect) and geographic/product expansion via the Sept 14, 2023…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.